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Introduction
In the secretory pathway, many secreted proteins or transmembrane proteins are initially synthesized as protein precursors and subsequently cleaved by proprotein convertases before they become fully functional. The cleavage of protein precursors by proprotein convertases is involved in the molecular pathogenesis of a wide range of human diseases including cancer, neurological disorders, autoimmune diseases and various viral infections [1] . So far, seven mammalian subtilisin/Kex2p-like proprotein convertases have been identified: furin, PC1/PC3/SPC3, PC2/SPC2, PC4/SPC5, PACE4/SPC4, PC5/PC6/SPC6 and PC7/PC8/SPC7/LPC. The binding pockets of all seven proprotein convertases are evolutionarily conserved and highly similar [2, 3] . Among the seven mammalian proprotein convertases, the cleavage of furin is the best characterized. The 3D crystal structure of dec-RVKR-cmk inhibited mouse furin binding pocket has been solved by Henrich and co-workers [4] . Furthermore, in authors' recent study, instead of a canonical four-residue motif R-X-[K/R]-R↓, the furin cleavage site has been characterized as a 20-residue motif that can be divided into two parts with distinct physical properties: 1) a core region (8 amino acids, position P6-P2´) inside the furin binding pocket that contributes to the binding strength of the substrate and 2) two polar regions (8 amino acids, positions P7-P14; and 4 amino acids, positions P3´-P6´) outside the furin binding pocket that mainly contribute to the solvent accessibility of the substrate [5] .
The 3D structure of the furin binding pocket [4] and the physical properties of the core region P6-P2´ of the furin cleavage site motif [5] provide a template with which to compare the local structural-functional relationship of all mammalian proprotein convertases. In this report, a multiple sequence alignment of mammalian proprotein convertases was generated, and the physical properties of mutations in the binding pockets were examined. The functional consequences of mutations were interpreted using the 3D structure. The results indicated two residues that play a key role in regulation of the substrate specificity of mammalian proprotein convertases. This finding provides insights into the molecular evolution of the enzyme function of the proprotein convertase family. The comparison of 3D structures also suggested a novel design for specific small molecular inhibitors that will aid the study of the functional redundancy of mammalian proprotein convertases and the development of therapeutic applications.
Results and Discussion

3D Structural environment of binding pocket of furin
The eight amino acids of the core region P6-P2´ of a furin substrate are located inside the furin binding pocket and are the main factor determining the binding strength of a substrate [5] . The residues of the mouse furin binding pocket surrounding the core region P6-P2´ of furin substrates was analyzed in the 3D crystal structure of the dec-RVKR-cmk inhibited mouse furin binding pocket [4] and also in the authors' recent study on the furin cleavage site motif [5] . Table 1 lists the structural environment surrounding the substrate positions P6-P2´. Table 1 . List of substrate positions and their interacting residues in the mouse furin binding pocket, which explain the substrate specificity of furin and the favoured physical properties at substrate position P6-P2'. The residues were retrieved from the 3D structure of the dec-RVKR-cmk inhibited mouse furin binding pocket (Protein Data Bank ID: IP8J) [4] .
Substrate position
Main interaction partners: residues and positions in the mouse furin binding pocket
Comparison of the 3D structural environment of binding pockets of seven mammalian proprotein convertases
To study the substrate specificity of the other six proprotein convertases (PC1, PC2, PC4, PACE4, PC5 and PC7), the 3D structural environments provided by these six different mammalian proprotein convertases were compared against furin. A multiple sequence alignment of the binding pockets of seven mammalian proprotein convertases was generated using Clustalx [6] and are publicly available on the associated website www.nuolan.org. The residue positions (listed in Table 1 ) of the binding pockets surrounding the core region P6-P2´ were examined in the multiple sequence alignment and mutations were identified Black indicates conserved residues. Blue indicates that a mutation changes the amino acid type but does not significantly affect the physical properties of the side chain of an amino acid. Red indicates that a mutation affects the physical properties of the side chain of an amino acid. The multiple sequence alignment was generated with Clustalx [6] .
Generally, changes in amino acids at specific positions in the binding pockets can be classified into three types:
1. Conserved. Marked in black in Figure 1 , e.g. Asp153.
2. Amino acid is mutated in one or more proprotein convertases, but the physical properties of the mutated amino acids can be considered as conserved and the favoured interaction between a substrate and a furin binding pocket at this position can still be maintained by the mutated amino acid in the 3D structure. These are marked in blue in Figure 1 , e.g. Asp264->Glu264 in PC1.
3. Amino acid is mutated in one or more proprotein convertases and the physical properties of the mutated amino acids are changed. These are marked in red in Figure 1 , e.g. Glu230->Pro230 in PC7. 
It is striking that mutations in Glu230 or Glu257 were repeatedly observed, these being key residues interacting with substrate positions P4-P6 (Figure 2) . Two of the most notable features and interactions at substrate positions P4-P6 have been observed in previous experiments [2, 3, [7] [8] [9] and can be explained by the 3D structure in this region:
1. Sensitivity to positive charge: a positively charged residue such as arginine and lysine at substrate position P5 and P6 could increase the furin cleavage efficiency because it may interact with the negatively charged Glu230 or Glu257 of the furin binding pocket.
2. Compensatory effect for positive charge: a positively charged residue such as arginine and lysine is favoured at substrate position P4 because it may interact with the negatively charged Glu236 and Asp264 of the furin binding pocket. Loss of a positively charged residue at position P4 results in loss of favourable interactions between the positive charge and negative charge at substrate position P4. However, this loss can be compensated by the presence of a positively charged residue at substrate position P5 or P6. Known furin cleavage sites with this compensatory effect for positive charges include integrin alpha 4 precursor (HVISKR 597 ↓, GI_124945) [10] , pro-parathyroid hormone (KSVKKR 31 ↓, GI_4506267) [11] , vascular endothelial growth factor C precursor (HSIIRR 227 ↓, GI_1718154) [12] , albumin precursor (RGVFRR 24 ↓, GI_4502027) [13] , furin auto-cleavage site (RGVTKR 75 ↓, GI_120611) [14] , vitamin K-dependent protein C precursor (LRIRKR 42 ↓, GI_131067) [15] and integral membrane protein 2B (KGIQKR 243 ↓, GI_12643343) [16] .
It should be emphasized that what compensates for the loss of the positive charge at substrate position P4 is not the observed presence of a positive charge at substrate position P5 or P6, but the interaction force between the positive charge and negative charge formed at substrate position P5 or P6. Therefore, in order to maintain the sensitivity and compensatory effect of the positive charge at the substrate positions P4-P6, negatively charged residues are required in the binding pocket. Mutations in Glu230 or Glu257 change the overall negatively charged density of the binding pockets of the other six mammalian proprotein convertases, with profound functional consequences:
1. For mammalian PC1 and PC2, mutations in Glu230 or Glu257 result in the loss of the negative charge at these two positions. As a consequence, a positively charged residue at the substrate position P5 or P6 cannot interact with the negatively charged residues at position 230 and 257 of the binding pockets of PC1 and PC2, and therefore the presence of a positively charged residue at substrate position P5 and P6 may not effectively contribute to the cleavage efficiency of PC1 or PC2. Moreover, the observed compensatory effect of the positive charge over substrate positions P4-P6 on furin cleavage may be reduced for the cleavage of PC1 and PC2.
2. For mammalian PC4 and PC7, mutation in Glu230 results in the loss of one negative charge. However, mutation in Glu257 was not observed in the PC4 binding pocket, and Glu257 is mutated to Asp257, which preserves the negative charge in the PC7 binding pocket. The consequence of the loss of only one negative charge at position 230 is not very clear.
3. The mutations in the binding pocket of mammalian PACE4 and PC5 lead to residues with similar physical properties such as charge, hydrophobicity and volume. This suggests that of all the mammalian proprotein convertases, furin, PACE4 and PC5 may have the closest substrate specificity. This structure was modeled based on the published 3D structure of the furin catalytic domain in complex with an inhibitor (Protein Data Bank ID: IP8J) [4] . The figure was generated with Swiss-Pdb Viewer[17] and was modified from the authors' previous publication [5] .
Although these conclusions were entirely derived from the theoretical 3D structure study, they are supported by existing experimental data. The cleavage site of integrin alpha 4 precursor (HVISKR 597 ↓, GI_124945) lacks a positively charged residue at position P4, and compensates for this loss with a positively charged histidine at position P6 that is protonated in the acidic secretory compartments. By co-infecting furin-deficient LOVO cells with individual proprotein convertases and measuring immunoprecipitated products of cleavage, Bergeron and co-workers showed that processing of integrin alpha 4 precursor is performed efficiently by furin, PACE4 and PC5 (similar specificity), and much less effi-ciently by PC1 (reduced sensitivity for positive charge at position P6), and not by PC7 [10] . In another study, Hendy and co-workers co-expressed pro-parathyroid hormone and proprotein convertases in BSC-40 and GH4C1 cells. The mass spectrometric analysis indicated that the cleavage site of pro-parathyroid hormone (KSVKKR 31 ↓, GI_4506267) can be 2-4-fold more efficiently cleaved by furin than PC1 and PC2 [11] . Again, the pattern KSVKKR↓ is characterized by the efficient compensation for the absence of a positive charge at position P4 by the presence of a positive charge at P6, which is preserved for furin, but reduced for PC1 and PC2.
To summarize, a negatively charged density at position 230 and 257 is a key factor that regulates the substrate specificity of mammalian proprotein convertases. In the course of molecular evolution, the enzyme function of the mammalian proprotein convertase family seems to have been fine-tuned by adjusting the density of the negative charge of the binding pockets. While this mechanism is supported by both the theoretical approach and experimental data, it is not the only structural mechanism. Which amino acid is present at other substrate positions such as P1' and P2' and the solvent accessibility of the substrates also affect the cleavage efficiency. In addition, physical interaction between the substrates and binding pockets of proprotein convertases is not the only way in which cleavage is regulated; the function of proprotein convertases is also regulated at other levels such as the level of expression in different tissues, their sub-cellular localizations, and the acidity of the different secretory compartments.
Towards the design of specific small molecule inhibitors targeting furin, PACE4, PC5, PC4 and PC7
Cleavage of proprotein convertases can be efficiently inhibited by a small molecule dec-RVKR-cmk [18, 19] . The structure of dec-RVKR-cmk is characterized by positively charged residues at substrate positions P1, P2 and P4. Consequently, this small molecule dec-RVKR-cmk efficiently binds to all seven mammalian proprotein convertases, and only has limited use for studying the functional redundancy of mammalian proprotein convertases.
Specific short peptide inhibitors for only a specific group of proprotein convertases will aid the study of the functional redundancy of proprotein convertases. The results from a comparative study of the 3D structure immediately suggested a novel pattern for small molecule inhibitors targeting a specific group of mammalian proprotein convertases. The general 3D structure of this small molecule is similar to that of short peptides [K/R]-X-V-X-K-R, which omit a positively charged residue at position P4, but add a positively charged residue at position P6. The loss of the negative charge on Glu230 and Glu257 of the PC1 and PC2 binding pocket likely results in reduced sensitivity to the positive charge at substrate positions P5 and P6, whereas at least one negative charge is conserved at Glu230 or Glu257 in the binding pockets of the other five mammalian proprotein convertases: furin, PACE4, PC5, PC4 and PC7. Therefore, a short peptide [K/R]-X-V-X-K-R, with no positive charge at position P4 and one positive charge at position P6, should have a higher affinity to furin, PACE4, PC5, PC4 and PC7 than to PC1 and PC2.
Interestingly, in the course of molecular evolution, PC1 and PC2 have acquired very different tissue distributions from the other five mammalian proprotein convertases [2] : PC1 and PC2 are highly expressed in neuroendocrine tissue; PC4 is highly expressed in the testicular and ovarian tissues; furin, PACE4, PC5 and PC7 are widely expressed. Given the different expression levels of the different mammalian proprotein convertases in the various tissue types, a small specific molecular inhibitor specifically targeting furin, PACE4, PC5, PC4 and PC7 would be especially interesting for the development of therapeutic applications. Various derivatives of this novel short peptide pattern [K/R]-X-V-X-K-R need to be tested for the optimal binding affinity and specificity, and further work is needed to confirm their potential.
Materials and Methods
Analysis of 3D structural environment of the mouse furin binding pocket
The 3D crystal structure of the dec-RVKR-cmk inhibited mouse furin binding pocket was retrieved from the Protein Data Bank ID:IP8J [4] . To analyse the 3D structure of the active site and calculate hydrogen bonds of molecular interactions, Swiss-PDB Viewer[17] was used and the procedures described by Guex et al. on the Swiss-Pdb Viewer site http://www.expasy.org/spdbv/ were followed.
Multiple sequence alignment of mammalian proprotein convertases
The mammalian orthologues of seven proprotein convertases (furin, PC1/PC3/SPC3, PC2/SPC2, PC4/SPC5, PACE4/SPC4, PC5/PC6/SPC6 and PC7/PC8/SPC7/LPC) were identified by the BLAST algorithm [20] . Five mammal species with relatively well-assembled genomes were selected: Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus and Canis familiaris. A multiple sequence alignment was produced by Clustalx [6] .
Conclusions
Our results extended our previous study on the physical properties of a 20-residue furin cleavage motif by determining the functional consequences of mutations at two specific positions (230 and 257) of the binding pockets of the other six mammalian proprotein convertases. We showed that the residues at positions 230 and 257 are frequently mutated in the binding pocket of mammalian proprotein convertases, resulting in a change in the density of the negative charge of the binding pockets. Comparison of the 3D structures suggests that different proprotein convertases have different sensitivities for the positive charge at substrate positions P5 and P6. Specifically, PC1 and PC2 may have reduced sensitivity for positively charged residues at the substrate position P5 or P6, whereas the substrate specificities of furin, PACE4, and PC5 may be very similar to each other. The density of the negative charge of the binding pockets seems to have played a key role in the molecular evolution of the enzyme function of the mammalian proprotein convertase family. This may allow the rational design of novel specific molecular inhibitors targeting specific members of the mammalian proprotein convertase family.
